Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial

Gilbert Peter B. (), Blette Bryan S., Hudgens Michael G. and Shepherd Bryan E.
Additional contact information
Gilbert Peter B.: Department of Biostatistics, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States of America
Hudgens Michael G.: Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, 27599, United States of America
Shepherd Bryan E.: Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232, United States of America

Journal of Causal Inference, 2020, vol. 8, issue 1, 54-69

Abstract: While the HVTN 505 trial showed no overall efficacy of the tested vaccine to prevent HIV infection over placebo, markers measuring immune response to vaccination were strongly correlated with infection. This finding generated the hypothesis that some marker-defined vaccinated subgroups were partially protected whereas others had their risk increased. This hypothesis can be assessed using the principal stratification framework (Frangakis and Rubin, 2002) for studying treatment effect modification by an intermediate response variable, using methods in the sub-field of principal surrogate (PS) analysis that studies multiple principal strata. Unfortunately, available methods for PS analysis require an augmented study design not available in HVTN 505, and make untestable structural risk assumptions, motivating a need for more robust PS methods. Fortunately, another sub-field of principal stratification, survivor average causal effect (SACE) analysis (Rubin, 2006) – which studies effects in a single principal stratum – provides many methods not requiring an augmented design and making fewer assumptions. We show how, for a binary intermediate response variable, methods developed for SACE analysis can be adapted to PS analysis, providing new and more robust PS methods. Application to HVTN 505 supports that the vaccine partially protected individuals with vaccine-induced T-cells expressing certain combinations of functions.

Keywords: Principal stratification; Randomized clinical trial; Two-phase sampling (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1515/jci-2019-0022 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:causin:v:8:y:2020:i:1:p:54-69:n:7

DOI: 10.1515/jci-2019-0022

Access Statistics for this article

Journal of Causal Inference is currently edited by Elias Bareinboim, Jin Tian and Iván Díaz

More articles in Journal of Causal Inference from De Gruyter
Bibliographic data for series maintained by Peter Golla ().